C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients-Reference-Cited by-同舟云学术

C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients

Published:2005-01 Issue:1 Volume:18 Page:116-124
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transplant Int

Author:

Caforio Alida L. P.,Tona Francesco,Piaserico Stefano,Gambino Antonio,Feltrin Giuseppe,Fortina Anna Belloni,Angelini Annalisa,Alaibac Mauro,Bontorin Martina,Calzolari Diego,Peserico Andrea,Thiene Gaetano,Iliceto Sabino,Gerosa Gino

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1432-2277.2004.00001.x/fullpdf

Reference36 articles.

1. INDIVIDUALIZATION OF CYCLOSPORINE THERAPY USING PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS

2. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation

3. VARIABLE ORAL ABSORPTION OF CYCLOSPORINE

4. REDUCED INTER- AND INTRASUBJECT VARIABILITY IN CYCLOSPORINE PHARMACOKINETICS IN RENAL TRANSPLANT RECIPIENTS TREATED WITH A MICROEMULSION FORMULATION IN CONJUNCTION WITH FASTING, LOW-FAT MEALS, OR HIGH-FAT MEALS1,2

5. NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVE

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LC-MS/MS and EMIT measure the whole blood concentration of cyclosporine A: The two methods yield concordant results within the dynamic range of the latter, but the former shows broader application scenarios;Journal of Chromatography B;2024-06

2. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08

3. Ciclosporin;Meyler's Side Effects of Drugs;2016

4. CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients;Int. Journal of Clinical Pharmacology and Therapeutics;2013-06-01

5. Comparing Antihypertensive Effect and Plasma Ciclosporin Concentration between Amlodipine and Valsartan Regimens in Hypertensive Renal Transplant Patients Receiving Ciclosporin Therapy;American Journal Cardiovascular Drugs;2011-12